NO893373L - Et humant rhino-virus-reseptor-protein som hemmer virusinfeksjon. - Google Patents
Et humant rhino-virus-reseptor-protein som hemmer virusinfeksjon.Info
- Publication number
- NO893373L NO893373L NO89893373A NO893373A NO893373L NO 893373 L NO893373 L NO 893373L NO 89893373 A NO89893373 A NO 89893373A NO 893373 A NO893373 A NO 893373A NO 893373 L NO893373 L NO 893373L
- Authority
- NO
- Norway
- Prior art keywords
- receptor
- hrv
- virus
- detergent
- receptor protein
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/70503—Immunoglobulin superfamily
- C07K14/70525—ICAM molecules, e.g. CD50, CD54, CD102
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US23957188A | 1988-09-01 | 1988-09-01 | |
US26242888A | 1988-10-25 | 1988-10-25 | |
US39066289A | 1989-08-10 | 1989-08-10 |
Publications (2)
Publication Number | Publication Date |
---|---|
NO893373D0 NO893373D0 (no) | 1989-08-22 |
NO893373L true NO893373L (no) | 1990-03-02 |
Family
ID=27399251
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO89893373A NO893373L (no) | 1988-09-01 | 1989-08-22 | Et humant rhino-virus-reseptor-protein som hemmer virusinfeksjon. |
Country Status (15)
Country | Link |
---|---|
US (1) | US7132395B1 (de) |
EP (1) | EP0362531B1 (de) |
JP (1) | JP3253064B2 (de) |
AT (1) | ATE186552T1 (de) |
AU (1) | AU637324B2 (de) |
CA (1) | CA1339193C (de) |
DE (1) | DE68929096T2 (de) |
DK (1) | DK174095B1 (de) |
ES (1) | ES2141076T3 (de) |
FI (1) | FI894065A (de) |
GR (1) | GR3032456T3 (de) |
IL (1) | IL91454A (de) |
NO (1) | NO893373L (de) |
NZ (1) | NZ230474A (de) |
PT (1) | PT91570B (de) |
Families Citing this family (42)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0303692A4 (en) * | 1987-02-26 | 1990-12-05 | Dana Farber Cancer Institute | Cloning of lfa-1 |
US5151267A (en) * | 1988-07-15 | 1992-09-29 | University Of Saskatchewan | Bovine herpesvirus type 1 polypeptides and vaccines |
US5585264A (en) * | 1988-07-15 | 1996-12-17 | University Of Saskatchewan | Nucleotide sequences encoding recombinant bovine herpesvirus type-1 GI, GIII and GIV polypeptides |
US6051231A (en) * | 1988-09-01 | 2000-04-18 | Bayer Corporation | Antiviral methods and prepations |
ATE186552T1 (de) | 1988-09-01 | 1999-11-15 | Bayer Ag | Menschliches rhinovirusrezeptorprotein, das die virusinfektionsanfälligkeit hemmt |
US6514936B1 (en) | 1988-09-01 | 2003-02-04 | Bayer Corporation | Antiviral methods using human rhinovirus receptor (ICAM-1) |
ZA896668B (en) * | 1988-09-01 | 1990-06-27 | Molecular Therapeutics Inc | A human rhinovirus receptor protein that inhibits virus infectivity |
US6143298A (en) * | 1988-09-01 | 2000-11-07 | Bayer Corporation | Soluble truncated forms of ICAM-1 |
NO900155L (no) * | 1989-01-24 | 1990-07-25 | Molecular Therapeutics Inc | Et opploeselig molekyl som er relatert til, men forskjellig fra icam-1. |
JPH04505009A (ja) * | 1989-03-09 | 1992-09-03 | ダナ・ファーバー・キャンサー・インスティチュート | クローニングlfa―1 |
ATE146968T1 (de) * | 1989-03-16 | 1997-01-15 | Blood Res Center | Verwendung von funkionellen derivaten des interzellulär-adhäsions-moleküls icam-1 in einer antivirus-therapie |
WO1991018010A1 (en) * | 1990-05-15 | 1991-11-28 | Swinburne Limited | Inhibition of viral infection using intercellular adhesion molecule-1-like peptides and/or analogues thereof |
ATE184049T1 (de) * | 1990-07-20 | 1999-09-15 | Bayer Ag | Multimere formen des menschlichen rhinovirus- rezeptorproteins |
US5871733A (en) * | 1990-07-20 | 1999-02-16 | Bayer Corporation | Multimeric forms of human rhinovirus receptor protein |
US6107461A (en) * | 1990-07-20 | 2000-08-22 | Bayer Corporation | Multimeric forms of human rhinovirus receptor and fragments thereof, and method of use |
US5674982A (en) * | 1990-07-20 | 1997-10-07 | Bayer Corporation | Multimeric form of human rhinovirus receptor protein |
US6130202A (en) * | 1990-07-20 | 2000-10-10 | Bayer Corporation | Antiviral methods |
US5288854A (en) * | 1990-11-28 | 1994-02-22 | Center For Blood Research, Inc. | Functional derivatives of ICAM-1 which are substantially capable of binding to LFA-1 but are substantially incapable of binding to MAC-1 |
US5629162A (en) * | 1991-06-11 | 1997-05-13 | The Center For Blood Research | Method of identifying agents which modulate ICAM-3 binding to LFA-1 |
US6100383A (en) * | 1992-01-27 | 2000-08-08 | Icos Corporation | Fusion proteins comprising ICAM-R polypeptides and immunoglobulin constant regions |
US6818743B1 (en) | 1992-01-27 | 2004-11-16 | Icos Corporation | I-CAM related protein |
WO1993014776A1 (en) * | 1992-01-27 | 1993-08-05 | Icos Corporation | Icam-related protein |
US5773218A (en) * | 1992-01-27 | 1998-06-30 | Icos Corporation | Method to identify compounds which modulate ICAM-related protein interactions |
US6153395A (en) * | 1992-01-27 | 2000-11-28 | Icos Corporation | ICAM-related protein |
US5989843A (en) * | 1992-01-27 | 1999-11-23 | Icos Corporation | Methods for identifying modulators of protein kinase C phosphorylation of ICAM-related protein |
US5837822A (en) * | 1992-01-27 | 1998-11-17 | Icos Corporation | Humanized antibodies specific for ICAM related protein |
US5532127A (en) * | 1992-01-27 | 1996-07-02 | Icos Corporation | Assay for 1-CAM related protein expression |
US5525487A (en) * | 1992-01-27 | 1996-06-11 | Icos Corporation | DNA encoding I-CAM related protein |
AU710965B2 (en) * | 1992-06-22 | 1999-09-30 | Bayer Corporation | Multimeric forms of human rhinovirus receptor protein |
WO1994011400A1 (en) * | 1992-11-18 | 1994-05-26 | Helsinki University Licensing Ltd. Oy | Peptides from human icam-2 and from human icam-1 and their analogs for use in therapy and diagnosis |
GB9414966D0 (en) * | 1994-07-26 | 1994-09-14 | Danbiosyst Uk | Pharmaceutical compositions for the nasal administration of antiviral agents |
US5879712A (en) * | 1995-06-07 | 1999-03-09 | Sri International | Method for producing drug-loaded microparticles and an ICAM-1 dosage form so produced |
WO1997032596A1 (en) * | 1996-03-06 | 1997-09-12 | Boehringer Ingelheim Pharmaceuticals, Inc. | Intercellular adhesion molecule powder formulation |
US6391452B1 (en) | 1997-07-18 | 2002-05-21 | Bayer Corporation | Compositions for nasal drug delivery, methods of making same, and methods of removing residual solvent from pharmaceutical preparations |
PT1682537E (pt) | 2003-11-05 | 2012-06-20 | Sarcode Bioscience Inc | Moduladores de adesão celular |
LT2444079T (lt) | 2005-05-17 | 2017-03-27 | Sarcode Bioscience Inc. | Kompozicijos ir būdai, skirti akių sutrikimų gydymui |
MX2010004281A (es) | 2007-10-19 | 2010-09-10 | Sarcode Corp | Composiciones y metodos para el tratamiento de la retinopatia diabetica. |
WO2009139817A2 (en) | 2008-04-15 | 2009-11-19 | Sarcode Corporation | Crystalline pharmaceutical and methods of preparation and use thereof |
US8378105B2 (en) | 2009-10-21 | 2013-02-19 | Sarcode Bioscience Inc. | Crystalline pharmaceutical and methods of preparation and use thereof |
EP3715345B1 (de) | 2012-07-25 | 2024-04-10 | Novartis AG | Herstellung eines lfa-1-hemmers |
US20170360815A1 (en) | 2016-02-25 | 2017-12-21 | Applied Biological Laboratories, Inc. | Compositions and methods for protecting against airborne pathogens and irritants |
KR20180120204A (ko) | 2016-02-25 | 2018-11-05 | 어플라이드 바이올로지컬 래버러토리즈 인코포레이티드 | 공기 매개 병원체 및 자극물질에 대한 보호용 조성물 및 방법 |
Family Cites Families (68)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4209526A (en) | 1977-08-05 | 1980-06-24 | Sterling Drug Inc. | Antiviral arylenedioxyalkyl substituted pyrazoles |
US4261928A (en) | 1977-08-05 | 1981-04-14 | Sterling Drug Inc. | 2-Benzoyl-8-(2-chloro-4-methoxyphenoxy)-1-phenyl-1-octanone |
US4171365A (en) | 1977-08-05 | 1979-10-16 | Sterling Drug Inc. | Antiviral aryloxyalkylpyrazoles |
GB2022826A (en) | 1978-06-12 | 1979-12-19 | Corning Glass Works | Measuring Antigen Receptors on Cell Membranes |
US4234725A (en) | 1979-10-24 | 1980-11-18 | Sterling Drug Inc. | 4-[6-(2-Chloro-4-methoxyphenoxy)hexyl]-3,5-diethyl-1-[4-(4-morpholinyl)-1-oxobutyl]-1H-pyrazole |
US4232161A (en) | 1979-10-24 | 1980-11-04 | Sterling Drug Inc. | 4-[6-(2-Chloro-4-methoxyphenoxy)hexyl]-3,5-diethyl-1-(2-pyridinyl)-1H-pyrazole |
US5179017A (en) | 1980-02-25 | 1993-01-12 | The Trustees Of Columbia University In The City Of New York | Processes for inserting DNA into eucaryotic cells and for producing proteinaceous materials |
US4427653A (en) | 1981-01-26 | 1984-01-24 | President And Fellows Of Harvard College | Method of making monoclonal antibodies |
US4372976A (en) | 1981-08-07 | 1983-02-08 | Sterling Drug Inc. | Novel aryl-aliphatic ketone and its use as an antiviral agent |
US4451476A (en) | 1982-12-13 | 1984-05-29 | Sterling Drug Inc. | Isoxazoles as antiviral agents |
US4843087A (en) | 1983-08-29 | 1989-06-27 | Sterling Drug Inc. | Di-heterocyclic compounds and their use as antiviral agents |
EP0169146A3 (de) * | 1984-07-20 | 1988-07-20 | Merck & Co. Inc. | Monoklonale Antikörper gegen den Rezeptor des menschlichen Rhinovirus |
JPS6181798A (ja) | 1984-07-23 | 1986-04-25 | ベクトン・デイツキンソン・アンド・カンパニ− | 細胞リセプタ−の回収 |
DE3505148A1 (de) | 1985-02-15 | 1986-10-30 | Boehringer Ingelheim International GmbH, 6507 Ingelheim | Polypeptide des rhinovirusstammes hrv2 sowie die hierfuer codierenden dna-molekuele |
CA1280753C (en) | 1985-07-02 | 1991-02-26 | Philip Michael Carabateas | Process for preparing heterocyclic substituted- phenoxyalkyl isoxazoles and-furans |
EP0227604A3 (de) | 1985-12-23 | 1989-01-18 | Sandoz Ag | Verwendung von Oligopeptiden in der Behandlung von viralen Infektionen |
EP0261403A3 (de) | 1986-08-23 | 1988-04-13 | BOEHRINGER INGELHEIM INTERNATIONAL GmbH | Polypeptide des Rhinovirusstammes HRV89 sowie die hierfür codierenden DNA-Moleküle |
JPS63276494A (ja) | 1987-02-26 | 1988-11-14 | ダナーファーバー・キャンサー・インスチチュート・インコーポレーテッド | Lfa−3の精製法 |
DE3712678A1 (de) | 1987-04-14 | 1988-10-27 | Boehringer Ingelheim Int | Rezeptor der kleinen rhinovirus rezeptor gruppe |
US5603932A (en) | 1987-04-14 | 1997-02-18 | Boehringer Ingelheim International Gmbh | Receptor of the minor human rhinovirus receptor group |
US5304636A (en) | 1987-04-14 | 1994-04-19 | Boehringer Ingelheim International Gmbh | Receptor for the human rhinovirus minor group |
US5831036A (en) | 1987-05-04 | 1998-11-03 | Dana Farber Cancer Institute | Soluble fragments of human intercellular adhesion molecule-1 |
AU629189B2 (en) | 1987-05-04 | 1992-10-01 | Dana-Farber Cancer Institute | Intercellular adhesion molecules and their binding ligands |
ES2080044T3 (es) | 1987-05-04 | 1996-02-01 | Dana Farber Cancer Inst Inc | Moleculas de adhesion intercelular y sus ligandos de fijacion. |
US5284931A (en) | 1987-05-04 | 1994-02-08 | Dana Farber Cancer Institute | Intercellular adhesion molecules, and their binding ligands |
US4956281A (en) | 1987-06-03 | 1990-09-11 | Biogen, Inc. | DNA sequences, recombinant DNA molecules and processes for producing lymphocyte function associated antigen-3 |
US5109123A (en) | 1988-06-14 | 1992-04-28 | Dana Farber Cancer Institute | Alteration of ability of soluble CD4 fragments to bind HIV |
DE3852374T2 (de) | 1987-11-02 | 1995-05-04 | Baylor College Medicine | Verwendung von ICAM-1 oder ihre funktionelle Derivate zur Behandlung unspezifischer Entzündungen. |
US5081228A (en) | 1988-02-25 | 1992-01-14 | Immunex Corporation | Interleukin-1 receptors |
CA1341055C (en) * | 1987-12-08 | 2000-07-18 | Alan Mcclelland | Transfectant cell lines which express the major human rhinovirus receptor |
US5395929A (en) | 1987-12-15 | 1995-03-07 | Dana Farber Cancer Institute | Isolated nucleic acid encoding the alpha subunit of the human leukocyte adhesion receptor |
EP0362526B1 (de) | 1988-08-23 | 1995-06-14 | Dana Farber Cancer Institute | Alpha-Subeinheit des LFA-1-Leukocyt-Adhäsions-Rezeptors |
US6514936B1 (en) * | 1988-09-01 | 2003-02-04 | Bayer Corporation | Antiviral methods using human rhinovirus receptor (ICAM-1) |
ZA896668B (en) * | 1988-09-01 | 1990-06-27 | Molecular Therapeutics Inc | A human rhinovirus receptor protein that inhibits virus infectivity |
US6143298A (en) | 1988-09-01 | 2000-11-07 | Bayer Corporation | Soluble truncated forms of ICAM-1 |
US6051231A (en) | 1988-09-01 | 2000-04-18 | Bayer Corporation | Antiviral methods and prepations |
ATE186552T1 (de) | 1988-09-01 | 1999-11-15 | Bayer Ag | Menschliches rhinovirusrezeptorprotein, das die virusinfektionsanfälligkeit hemmt |
ES2201052T3 (es) | 1988-09-28 | 2004-03-16 | Dana Farber Cancer Institute | Moleculas de adhesion intercelular y sus ligandos de union. |
US5372933A (en) | 1988-10-03 | 1994-12-13 | The Scripps Research Institute | Polypeptides that mimic receptor-induced binding sites, and methods of using same |
CA2008368C (en) | 1989-01-24 | 2003-04-08 | Jeffrey Greve | Soluble molecule related to but distinct from icam-1 |
NO900155L (no) * | 1989-01-24 | 1990-07-25 | Molecular Therapeutics Inc | Et opploeselig molekyl som er relatert til, men forskjellig fra icam-1. |
US5235049A (en) | 1989-01-24 | 1993-08-10 | Molecular Therapeutics, Inc. | Nucleic acid sequences encoding a soluble molecule (SICAM-1) related to but distinct from ICAM-1 |
PT92900A (pt) | 1989-01-24 | 1990-07-31 | Sistema de vectores de expressao para a producao de anticorpos monoclonais quimericos | |
DK0387701T3 (da) | 1989-03-09 | 1992-12-07 | Boehringer Ingelheim Pharma | Anvendelse af intercellulære adhæsionsmolekyler samt deres bindende ligander ved behandling af astma |
HU217792B (hu) | 1989-03-16 | 2000-04-28 | Dana Farber Cancer Institute | Eljárás intercelluláris adhéziós molekula (ICAM-1) oldható származékai és ezeket tartalmazó gyógyszerkészítmények előállítására |
ATE146968T1 (de) * | 1989-03-16 | 1997-01-15 | Blood Res Center | Verwendung von funkionellen derivaten des interzellulär-adhäsions-moleküls icam-1 in einer antivirus-therapie |
US5324510A (en) | 1989-09-01 | 1994-06-28 | Boehringer Ingelheim Pharmaceuticals, Inc. | Use of antibodies to intercellular adhesion molecule-1 (ICAM-1) in the treatment of asthma |
EP0459577A3 (en) | 1990-06-01 | 1992-08-05 | Merck & Co. Inc. | Microbially expressed portions of a monoclonal antibody block rhinovirus attachment to cell receptors |
US5349053A (en) | 1990-06-01 | 1994-09-20 | Protein Design Labs, Inc. | Chimeric ligand/immunoglobulin molecules and their uses |
US6130202A (en) * | 1990-07-20 | 2000-10-10 | Bayer Corporation | Antiviral methods |
US5674982A (en) | 1990-07-20 | 1997-10-07 | Bayer Corporation | Multimeric form of human rhinovirus receptor protein |
US5871733A (en) | 1990-07-20 | 1999-02-16 | Bayer Corporation | Multimeric forms of human rhinovirus receptor protein |
US6107461A (en) | 1990-07-20 | 2000-08-22 | Bayer Corporation | Multimeric forms of human rhinovirus receptor and fragments thereof, and method of use |
ATE184049T1 (de) | 1990-07-20 | 1999-09-15 | Bayer Ag | Multimere formen des menschlichen rhinovirus- rezeptorproteins |
AU8631991A (en) | 1990-08-27 | 1992-03-17 | Cetus Corporation | Cd18 peptide medicaments for the treatment of disease |
US5288854A (en) | 1990-11-28 | 1994-02-22 | Center For Blood Research, Inc. | Functional derivatives of ICAM-1 which are substantially capable of binding to LFA-1 but are substantially incapable of binding to MAC-1 |
EP0517895B1 (de) | 1990-12-14 | 1996-11-20 | Cell Genesys, Inc. | Chimärische ketten zur transduktion von rezeptorverbundenen signalwegen |
EP0510483A1 (de) | 1991-04-22 | 1992-10-28 | Boehringer Ingelheim Pharmaceuticals Inc. | Verfahren zum Nachweis von Viren |
US5223396A (en) | 1991-05-03 | 1993-06-29 | Boehringer Ingelheim Pharmaceuticals, Inc. | Method for detecting organ transplant rejection |
US5240694A (en) | 1991-09-23 | 1993-08-31 | University Of Virginia | Combined antiviral and antimediator treatment of common colds |
WO1993006865A1 (en) | 1991-10-04 | 1993-04-15 | The United States of America, represented by The Secretary, Department of Health & Human Services | Treatment of ocular inflammation by blockage of cell adhesion molecules |
US5525487A (en) | 1992-01-27 | 1996-06-11 | Icos Corporation | DNA encoding I-CAM related protein |
WO1993014776A1 (en) | 1992-01-27 | 1993-08-05 | Icos Corporation | Icam-related protein |
US5532127A (en) | 1992-01-27 | 1996-07-02 | Icos Corporation | Assay for 1-CAM related protein expression |
PT566554E (pt) | 1992-03-13 | 2000-09-29 | Monsanto Co | Producao de proteinas recombinantes usando promotores do virus de herpes e transactivadores vp16 |
AU675441B2 (en) | 1992-06-22 | 1997-02-06 | Bayer Corporation | Multimeric forms of human rhinovirus receptor protein |
US5580969A (en) | 1992-07-24 | 1996-12-03 | The United States Of America As Represented By The Secretary Of The Navy | Antisense oligonucleotides directed against human ICAM-I RNA |
US5879712A (en) | 1995-06-07 | 1999-03-09 | Sri International | Method for producing drug-loaded microparticles and an ICAM-1 dosage form so produced |
-
1989
- 1989-08-19 AT AT89115358T patent/ATE186552T1/de not_active IP Right Cessation
- 1989-08-19 DE DE68929096T patent/DE68929096T2/de not_active Expired - Lifetime
- 1989-08-19 ES ES89115358T patent/ES2141076T3/es not_active Expired - Lifetime
- 1989-08-19 EP EP89115358A patent/EP0362531B1/de not_active Expired - Lifetime
- 1989-08-22 NO NO89893373A patent/NO893373L/no unknown
- 1989-08-25 AU AU40271/89A patent/AU637324B2/en not_active Ceased
- 1989-08-25 CA CA000609473A patent/CA1339193C/en not_active Expired - Fee Related
- 1989-08-28 IL IL9145489A patent/IL91454A/en not_active IP Right Cessation
- 1989-08-29 NZ NZ230474A patent/NZ230474A/xx unknown
- 1989-08-30 FI FI894065A patent/FI894065A/fi not_active Application Discontinuation
- 1989-08-30 PT PT91570A patent/PT91570B/pt not_active IP Right Cessation
- 1989-08-31 DK DK198904312A patent/DK174095B1/da not_active IP Right Cessation
- 1989-09-01 JP JP22730189A patent/JP3253064B2/ja not_active Expired - Lifetime
-
1994
- 1994-09-30 US US08/316,384 patent/US7132395B1/en not_active Expired - Fee Related
-
2000
- 2000-01-25 GR GR20000400150T patent/GR3032456T3/el not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
DE68929096T2 (de) | 2000-05-11 |
AU4027189A (en) | 1990-03-08 |
JP3253064B2 (ja) | 2002-02-04 |
CA1339193C (en) | 1997-08-05 |
DE68929096D1 (de) | 1999-12-16 |
EP0362531A1 (de) | 1990-04-11 |
NO893373D0 (no) | 1989-08-22 |
NZ230474A (en) | 1993-03-26 |
DK431289A (da) | 1990-03-02 |
DK174095B1 (da) | 2002-06-10 |
IL91454A0 (en) | 1990-04-29 |
US7132395B1 (en) | 2006-11-07 |
JPH02238892A (ja) | 1990-09-21 |
GR3032456T3 (en) | 2000-05-31 |
PT91570B (pt) | 1995-05-31 |
DK431289D0 (da) | 1989-08-31 |
IL91454A (en) | 1995-08-31 |
ES2141076T3 (es) | 2000-03-16 |
EP0362531B1 (de) | 1999-11-10 |
FI894065A (fi) | 1990-03-02 |
AU637324B2 (en) | 1993-05-27 |
ATE186552T1 (de) | 1999-11-15 |
PT91570A (pt) | 1990-03-30 |
FI894065A0 (fi) | 1989-08-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO893373D0 (no) | Et humant rhino-virus-reseptor-protein som hemmer virusinfeksjon. | |
ATE98376T1 (de) | Synthetische htlv-iii-peptid-zusammensetzungen und ihre verwendung. | |
UA41870C2 (uk) | Спосіб направлення клітинної відповіді на інфекційний агент, клітину, інфіковану вказаним агентом, пухлинну, злоякісну клітину або аутоімунну клітину (варіанти), клітина, яка експресує мембранозв'язаний білковий химерний рецептор (варіанти), днк,що кодує химерний рецептор, вектор, спосіб лікування інфекції вірусу імунодефіциту(варіанти) | |
RU97115895A (ru) | Переключение клеточного иммунитета, осуществляемое с помощью тирозин-специфических протеинкиназных химер | |
DE69232906T2 (de) | Detektion des Hepatis-C Virus. | |
KR890002547A (ko) | Hiv 감염의 치료 및 진단용 모노클로날항체 및 펩티드 | |
KR890700683A (ko) | 인체 면역 결핍 바이러스에 대한 항체 검색 방법 | |
SE9201281D0 (sv) | New human monoclonal antibodies, and a method for preparation thereof | |
BE888855A (fr) | Procede d'obtention de preparations de toxoplasmes pour le diagnostic de la toxoplasmose, et preparations ainsi obtenues | |
TR27329A (tr) | Yeni metazoan parazit antigenler, bunlari kodlayan nükleik asidler. | |
Iversen et al. | The major internal protein, p27, of a retrovirus-like particle is expressed in blood lymphocytes from psoriatic patients | |
DK100888A (da) | Fremgangsmaade til at rense rekombinant pres-1/s-2/s hepatitis b antigen fra gaer | |
FR2655269B1 (fr) | Proteines empechant l'interaction entre un fragment fc d'une immunoglobuline et son recepteur et utilisation en therapeutique, notamment dans le traitement des affections liees aux virus hiv. | |
Papamichail et al. | Binding of native and aggregated human γ-globulin by mouse lymphoid cells and fibroblasts | |
Elliott et al. | Characterization of Functional Fc-Receptor Material from Human Lymphoblastoid Cell Lines: II. Serologic and Cellular Analysis | |
Zhang et al. | AChR specific T lymphocytes in Myasthenia Gravis | |
Azocar et al. | Lack of endemic HIV infection in Venezuela | |
Koethe et al. | Lysis of Neuraminidase-Treated Paroxysmal Nocturnal Hemoglobinuria (PNH) Erythrocytes in Normal Human Serum | |
Matsiota-Bernard et al. | Inhibition of in vitro HIV infection by trinitrophenyl-protein conjugates | |
DE4112743A1 (de) | Synthetische core-peptide zur bestimmung von hcv-antikoerpern und hcv-antigenen, mittel dazu und ihre verwendung in diesen nachweis-verfahren | |
Dandliker et al. | Kinetic investigations of antigen-antibody and hapten-antibody reactions | |
SE8701294D0 (sv) | Hiv-peptid | |
Doinel et al. | Activité biologique résiduelle des fragments d'une IgM agglutinine froide | |
EP0145589A3 (de) | Eukaryotische Zellkultur die ein vakzinierendes Protein, insbesondere das HBs-Antigen produziert | |
KR880010133A (ko) | Hiv 검출 및 치료를 위한 방법 및 물질 |